Notably, studies have demonstrated a higher prevalence of APOA5 copy number loss in intraductal tumors among East Asian women under the age of 50, suggesting its diverse involvement in tumor biology through immunomodulation within the tumor microenvironment (Lin et al. 2021). Here, APOA5 is linked to neoplasm.